More than 200 genes with novel and known roles in glioblastoma—the most aggressive type of brain cancer—offer promising new drug targets. Researchers from the Wellcome Sanger Institute, Addenbrooke's Hospital and their ...
Jul 29, 2020
0
176
Associate Professor Takeshi Kawano, Department of Electrical and Electronic Information Engineering, Toyohashi University of Technology (TUT) and the research team at the Electronics-Inspired Interdisciplinary Research Institute ...
Jul 29, 2020
0
1
Through a cross-species study of metformin, a common drug used to treat Type 2 diabetes, a team of researchers and clinicians from the Donnelly Center and The Hospital for Sick Children (SickKids) has shown that it could ...
Jul 28, 2020
0
977
In a vertical climb to avoid collision with a towering mountain, a plane ejects cargo to gain altitude. Investigators at the University of Minnesota showed that cancer cells perform similar feats in escaping the killing effects ...
May 14, 2020
0
0
People with the genetic condition neurofibromatosis type 1 (NF1) are prone to developing tumors on nervous system tissue. A new study from Washington University School of Medicine in St. Louis has found that the development ...
May 1, 2020
0
106
Findings from a new study examining human and canine brain cancer cells suggest that cannabidiol could be a useful therapy for a difficult-to-treat brain cancer. Cannabidiol, or CBD, is a non-psychoactive chemical compound ...
Apr 27, 2020
0
31
Preventing the death of neurons during brain growth means these 'zombie' cells can develop into functioning neurons, according to research in fruit flies from the Crick, the University of Lausanne (UNIL) and the Max Planck ...
Mar 11, 2020
0
395
Erythropoietin, or Epo for short, is a notorious doping agent. It promotes the formation of red blood cells, leading thereby to enhanced physical performance—at least, that is what we have believed until now. However, as ...
Mar 9, 2020
2
584
The International Parkinson Disease Genomics Consortium (IPDGC) has now been in existence for ten years. In an article published in the Journal of Parkinson's Disease the consortium reviews the progress made over the past ...
Jan 16, 2020
0
4
A UNC Lineberger team led by Timothy Gershon, MD, Ph.D., associate professor in the UNC Department of Neurology, and Kirk Wilhelmsen MD, Ph.D., professor in neurology and the UNC Department of Genetics, reported in the journal ...
Jan 14, 2020
0
26
